British American Tobaccoの空売り状況は、投資家がBritish American Tobaccoの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

British American Tobacco (NYSE:BTI) 株価情報, 空売り情報

British American Tobacco

British American Tobacco  Industries, p.l.c.

AMEX

The second-largest tobacco company by volume, British American Tobacco sold 555 billion cigarettes in 2023. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.

British American Tobacco Industries, p.l.c. Common Stock ADR

British American Tobacco PLC

Boatim Inc

As of Jan. 31, 2025, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">British American Tobacco PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>)</h3>
<ul>
<li>On Jan. 27, UBS analyst Faham Baig upgraded British American Tobacco from Neutral to Buy. The company's stock surged around 9% over the past month and has a <a href="https://www.benzinga.com/quote/BTI">52-week high of $39.76</a>.</li>
<li>RSI Value: 75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BTI Price Action: Shares of British American Tobacco gained 1.1% to close at $39.68 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Estee Lauder Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>)</h3>
<ul>
<li>On Jan. 30, Wells Fargo analyst Christopher Carey maintained Estee Lauder with an Equal-Weight rating and raised the price target from $74 to $80. The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/EL">has a 52-week high</a> of $62.29.</li>
<li>RSI Value: 77.1</li>
<li>EL Price Action: Shares of Estee Lauder gained 3.9% to close at $85.48 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Turning Point Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>)</h3>
<ul>
<li>On Jan. 10, Roth MKM analyst Scott Fortune reiterated Turning Point Brands with a Buy and maintained a $70 price target. The company's stock gained around 12% over the past five days and has a <a href="https://www.benzinga.com/quote/TPB">52-week high </a>of $66.18.</li>
<li>RSI Value: 73.1</li>
<li>TPB Price Action: Shares of Turning Point Brands gained 5.3% to close at $63.00 on Thursday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

Top 3 Defensive Stocks That May Implode In Q1

WIIM

British American Tobacco shares are trading higher after UBS upgraded the stock from Neutral to Buy.

UBS analyst Faham Baig upgrades British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) from Neutral to Buy.

Upgrades

Analyst Ratings

UBS Upgrades British American Tobacco to Buy

XXII

Menthol Cigarette Ban Withdrawn By Trump Administration

<a href="https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.">https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.</a>
&nbsp;
Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN nicotine pouch products through the <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">premarket tobacco product application (PMTA)</a> pathway following an extensive scientific review. This is the first time the agency has authorized products commonly referred to as <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">nicotine pouches</a>, which are small synthetic fiber pouches containing nicotine designed to be placed between a person's gum and lip. &nbsp;
The FDA determined that the specific products receiving marketing authorization met the <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">public health standard</a> legally required by the 2009 Family Smoking Prevention and Tobacco Control Act. This standard considers the risks and benefits of products to the population as a whole.&nbsp;
Among several key considerations, the agency's evaluation showed that, due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, such as moist snuff and snus, the authorized products pose lower risk of cancer and other serious health conditions than such products. The applicant also provided evidence from a study showing that a substantial proportion of adults who use cigarette and/or smokeless tobacco products completely switched to the newly authorized nicotine pouch products.

FDA Authorizes Marketing Of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review

<a href="https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today" title="https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today">https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today</a>

Biotech

Government

Regulations

General

'FDA Proposes Significant Step Toward Reducing Nicotine To Minimally Or Nonaddictive Level In Cigarettes And Certain Other Combusted Tobacco Products' - FDA

<a href="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html" title="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html">https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html</a>

"F.D.A. Tries Last-Ditch Move to Slash Nicotine Levels in Cigarettes; The agency is asking the White House to move ahead with plans to drastically reduce the addictive substance in traditional tobacco cigarettes." - NY Times

Lilly CEO Says To Test Obesity Drugs For Smoking, Alcohol Abuse

The U.S. Supreme Court heard a challenge against the Food and Drug Administration (FDA) Monday about past bans on flavored liquids for<a href="https://www.benzinga.com/topic/vaping"> e-cigarettes and vapes.</a>
What Happened: Triton Distribution brought a case to the<a href="https://www.benzinga.com/topic/supreme-court"> U.S. Supreme Court</a>, challenging the law that allows the FDA to control the regulation of e-liquids and e-cigarettes.
The FDA previously denied Triton&#8217;s applications to sell flavored e-cigarettes. The concern is that they could appeal to children and teenagers, as reported by <a href="https://www.politico.com/news/2024/12/02/supreme-court-vaping-firm-fda-00192164">Politico</a>.  
Cigarette flavors, except menthol, have been banned by the FDA since 2009.
A final ruling will not be made by the Supreme Court for months. Justices, though, don&#8217;t appear to sympathize with Triton's argument.
"Everybody basically knows that flavors are particularly dangerous in terms of kids starting the use of smoking products," Justice Elena Kagan said.
Triton has the potential to reapply with the FDA. A company attorney said the incoming Donald Trump administration could make things easier, given his past comments on wanting to <a href="https://www.usatoday.com/story/news/politics/2024/12/02/supreme-court-trump-flavored-vapes/76693085007/">save</a> vaping.
Some judges believed the FDA was not consistent on its approval process.
"Their argument is that the guidance were actually a moving target, that either they weren't clear, or you changed the guidance as time went on," Justice Clarence Thomas said.
Read Also: <a href="https://www.benzinga.com/news/24/09/40969670/trump-vows-to-save-vaping-again-despite-past-partial-ban-heres-how-he-plans-to-do-it">Trump Vows To &#8216;Save Vaping Again&#8217; Despite Past Partial Ban. Here&#8217;s How He Plans To Do It</a>
Why It's Important: Under the existing 2009 law, the FDA only approves new tobacco products if they believe they will protect public health. This makes it harder to get new products approved, as the system favors those fighting to get current users of products to stop smoking or prevent new users from starting.
Past appeals courts have approved the FDA's decisions, as reported by <a href="https://www.npr.org/2024/12/02/nx-s1-5205471/fda-vaping-supreme-court">NPR</a>. The conservative Fifth Circuit Court of Appeals rejected the FDA's decision capabilities. It also threatened to allow all vaping products to hit the market, prompting the challenge with the Supreme Court.
With a final ruling likely in June, cigarette and vaping companies could be on the radar of investors.
Cigarette manufacturer Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) owns the NJOY menthol e-cigarette product that has flavored vapes approved by the FDA. Altria was previously an investor in Juul, a leader in the e-cigarette sector. It eventually exchanged its stake for some intellectual property.
Maintaining the FDA's current rules would keep Altria as one of the only companies that can sell approved flavored e-cigarettes. A different decision could see Altria quickly face increased competition.
British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) has watched previous attempts to have some vaping products approved denied by the FDA.
Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPI#NYSE">TPI</a>), a past challenger to the FDA's approval process, could benefit if the Supreme Court puts new rules in place.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/10/41516090/social-media-reacts-as-juul-users-get-compensation-through-venmo-after-300m-class-action-settlements">Social Media Reacts As Juul Users Get Compensation Through Venmo After $300M Class-Action Settlements: &#8216;Vaping Actually Paid Off&#8217;</a></li>
</ul>
Image: Shutterstock

Legal

Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch

U.S. Supreme Court Declines To Decide Whether Certain Federally Mandated Health Warnings On Cigarette Packs Violate Tobacco Companies' Free Speech Protections

Guidance

British American Tobacco Backs 2024 Guidance

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Farmer Bros Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARM#NASDAQ">FARM</a>)</h3>
<ul>
<li>On Sept. 12, Farmer Bros reported better-than-expected fourth-quarter financial results. &#8220;This past year was a transformative one for Farmer Brothers,&#8221; said President and Chief Executive Officer John Moore. &#8220;The decision to sell our direct ship business and focus on our more profitable DSD business helped significantly improve our gross margins and drive adjusted EBITDA profitability and overall operational efficiency.&#8221; The company's stock fell around 30% over the past month and has a <a href="https://www.benzinga.com/quote/FARM">52-week low of $1.85</a>.</li>
<li>RSI Value: 27.27</li>
<li>FARM Price Action: Shares of Farmer Bros fell 2.1% to close at $1.89 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1">latest FARM news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="902" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065613/image-16.png" alt="" class="wp-image-580375" style="width:634px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065613/image-16.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065613/image-16-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065613/image-16-768x696.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">British American Tobacco PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On July 25, British American Tobacco posted H1 adjusted EPS of 169.3p down from 181.6p in the year-ago period. The company's stock fell around 6% over the past five days. It <a href="https://www.benzinga.com/quote/MMYT">has a 52-week low</a> of $28.25.</li>
<li>RSI Value: 24.49</li>
<li>BTI Price Action: Shares of British American Tobacco fell 2.4% to close at $35.11 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1">trend in BTI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="905" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065652/image-17.png" alt="" class="wp-image-580377" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065652/image-17.png 905w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065652/image-17-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065652/image-17-768x698.png 768w" sizes="(max-width: 905px) 100vw, 905px" /></a></figure>
<h3 class="wp-block-heading">Conagra Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>)</h3>
<ul>
<li>On Oct. 2, ConAgra Brands reported worse-than-expected first-quarter financial results. Conagra Brands reaffirmed its fiscal 2025 guidance, projecting organic net sales to be between a decline of 1.5% and flat compared to fiscal year 2024, and expects adjusted earnings per share (EPS) to be between $2.60 and $2.65, compared to an estimated $2.61. The company's shares fell around 10% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/CAG">low of $25.16</a>.</li>
<li>RSI Value: 25.52</li>
<li>CAG Price Action: Shares of Conagra Brands fell 2.4% to close at $29.35 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1">breakout in CAG shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="852" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065730/image-18.png" alt="" class="wp-image-580379" style="width:611px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065730/image-18.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065730/image-18-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04065730/image-18-768x721.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41173410/top-2-tech-and-telecom-stocks-that-are-ticking-portfolio-bombs">Top 2 Tech And Telecom Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Long Ideas

FARM

Top 3 Risk Off Stocks That May Explode This Month

Whales with a lot of money to spend have taken a noticeably bearish stance on British American Tobacco.
Looking at options history for British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 70% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $760,250 and 6, calls, for a total amount of $378,890.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $28.0 to $42.0 for British American Tobacco during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in British American Tobacco's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to British American Tobacco's substantial trades, within a strike price spectrum from $28.0 to $42.0 over the preceding 30 days.
<h3>British American Tobacco Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727370982_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$7.2</td>
<td>$6.8</td>
<td>$7.2</td>
<td>$40.00</td>
<td>$262.8K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">365</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.2</td>
<td>$4.9</td>
<td>$5.2</td>
<td>$37.00</td>
<td>$189.8K</td>
<td style="text-align: right;">23</td>
<td style="text-align: right;">730</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.1</td>
<td>$4.8</td>
<td>$5.1</td>
<td>$37.00</td>
<td>$186.1K</td>
<td style="text-align: right;">23</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$9.5</td>
<td>$8.1</td>
<td>$8.1</td>
<td>$42.00</td>
<td>$121.5K</td>
<td style="text-align: right;">134</td>
<td style="text-align: right;">150</td>
</tr>
<tr>
<td>BTI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$3.4</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$37.00</td>
<td>$109.5K</td>
<td style="text-align: right;">15</td>
<td style="text-align: right;">730</td>
</tr>
</tbody>
</table>

<h3>About British American Tobacco</h3>
The second-largest tobacco company by volume, British American Tobacco sold 555 billion cigarettes in 2023. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.
After a thorough review of the options trading surrounding British American Tobacco, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>British American Tobacco's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 3,193,902, the BTI's price is down by -0.03%, now at $37.95. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 12 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for British American Tobacco, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Looking At British American Tobacco's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on British American Tobacco. Our analysis of options history for British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) revealed 14 unusual trades.
Delving into the details, we found 42% of traders were bullish, while 28% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $109,361, and 11 were calls, valued at $501,442.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $32.0 to $40.0 for British American Tobacco over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for British American Tobacco options trades today is 2179.8 with a total volume of 5,347.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for British American Tobacco's big money trades within a strike price range of $32.0 to $40.0 over the last 30 days.
<h3>British American Tobacco Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726605064_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BTI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.9</td>
<td>$0.85</td>
<td>$0.9</td>
<td>$39.00</td>
<td>$90.0K</td>
<td>738</td>
<td>1.1K</td>
</tr>
<tr>
<td>BTI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$4.2</td>
<td>$4.1</td>
<td>$4.2</td>
<td>$34.00</td>
<td>$78.9K</td>
<td>4.1K</td>
<td>630</td>
</tr>
<tr>
<td>BTI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.0</td>
<td>$1.7</td>
<td>$1.8</td>
<td>$40.00</td>
<td>$54.1K</td>
<td>2.6K</td>
<td>301</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$0.7</td>
<td>$0.65</td>
<td>$0.66</td>
<td>$37.00</td>
<td>$53.1K</td>
<td>596</td>
<td>939</td>
</tr>
<tr>
<td>BTI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.2</td>
<td>$3.7</td>
<td>$4.01</td>
<td>$35.00</td>
<td>$40.1K</td>
<td>3.5K</td>
<td>293</td>
</tr>
</tbody>
</table>

<h3>About British American Tobacco</h3>
The second-largest tobacco company by volume, British American Tobacco sold 555 billion cigarettes in 2023. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.
Following our analysis of the options activities associated with British American Tobacco, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of British American Tobacco</h3>
<ul>
<li>With a volume of 5,754,079, the price of BTI is down -3.43% at $38.01. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 14 days.</li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest British American Tobacco options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

British American Tobacco Options Trading: A Deep Dive into Market Sentiment

Cannabis producer Organigram Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/OGI#TSX">OGI</a>) has closed the second of three tranches of the previously announced CA$124,559,674 ($92.3 million) follow-on strategic equity investment by BT DE Investments Inc., a wholly owned subsidiary of British American Tobacco plc, (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) on Tuesday.
Under the second tranche closing, the investor acquired Organigram's 4,429,740 common shares and 8,463,435 Class A preferred shares at CA$3.2203 per share, for gross proceeds of $30.8 million.
The company said on Tuesday that the remaining 12,893,175 shares subscribed for are due to be issued at the per-share price in the final tranche on or around February 28, 2025.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/03083439/ccc-oct-24-banner__1_.gif" alt="" class="wp-image-526880" /></figure>
"With two tranches of the Jupiter pool now funded, combined with our strong balance sheet and targeted investment strategy, Organigram is well on its way to executing on its ambitious growth plan focusing on international, technological and product expansion," Paolo De Luca, chief strategy officer of Organigram. "Our inaugural Jupiter investment in Open Book Extracts marked our second investment in the U.S. market, and our first international investment in Sanity Group represents a significant first step in our ambitions to grow our footprint in the fast-growing German market."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40337376/organigram-reports-25-yoy-increase-in-q3-net-revenue-significant-improvement-in-adjusted-ebitda">Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA</a> 
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">The Deal Details</h3>
Organigram first announced a CA$124.6 million follow-on strategic equity investment <a href="https://www.benzinga.com/markets/cannabis/23/11/35617810/69b-tobacco-giant-supports-cannabis-with-91m-investment-in-toronto-weed-producer">from BAT's subsidiary in November 2023</a>. In January 2024, Organigram shareholders voted to approve the investment from BAT, and the company completed the first of three tranches of the investment for proceeds of CA$41.5 million.
The investment allows Organigram to &#8220;fully leverage our world-class facilities, market leadership in several categories, and cutting-edge research and development capabilities to increase Organigram's reach both within the Canadian market and beyond," Beena Goldenberg, the company's CEO said earlier this year.
As previously announced, Organigram is using most of the investment to fund a strategic investment pool named Jupiter. This pool is designed to accelerate Organigram's international expansion and targets investments both overseas and in the U.S. Following the closing of the first tranche in January, Organigram has already made two important investments from the Jupiter Pool.
The first investment of $2 million was made in North Carolina-based hemp producer Open Book Extracts, while the second investment of €14 million ($15 million), was made in Sanity Group GmbH, a <a href="https://www.benzinga.com/markets/cannabis/24/06/39484091/organigram-supports-cannabis-in-germany-with-15m-initial-investment-in-this-berlin-marijuana-co">market leader in the fast-growing German medical market.</a>
BAT initially invested approximately CA$221 million into Organigram in March of 2021, which had served to propel product innovations resulting from CoE at the company's Moncton facility.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39720383/a-2-billion-opportunity-in-cannabis-how-a-tobacco-giant-is-helping-organigram-seize-the-german-m">A $2 Billion Opportunity In Cannabis: How A Tobacco Giant Is Helping Organigram Seize The German Market</a></li>
</ul>
<h3 class="wp-block-heading">OGI Price Action</h3>
Organigram's shares traded 0.54% lower at $1.84 per share during the pre-market session on Tuesday morning.

Cannabis

Financing

TSX:OGI

Tobacco Giant Invests $30.8M In Cannabis Company: BAT Private Placement Second Of Three Tranches

FDA Issues Final Rule Increasing Minimum Age For Tobacco Sales Restrictions; From Sept. 30, Retailers Must Verify Age With Photo ID For Anyone Under 30 And Vending Machine Sales Will Be Limited To 21+ Facilities

As of July 25, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Unilever plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>)</h3>
<ul>
<li>On July 25, Unilever reported quarterly adjusted earnings of $1.74 per share. This is a 16.27% increase over earnings of $1.50 per share from the same period last year. The company reported $33.48 billion in sales this quarter. The company's stock gained around 19% over the past six months and has a <a href="https://www.benzinga.com/quote/UL">52-week high of $58.62</a>.</li>
<li>RSI Value: 71.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>UL Price Action: Shares of Unilever gained 0.04% to close at $56.54 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">British American Tobacco PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>)</h3>
<ul>
<li>On July 25, British American Tobacco posted H1 adjusted EPS of 169.3p down from 181.6p year over year. The company's stock gained around 4% over the past month and <a href="https://www.benzinga.com/quote/BTI">has a 52-week high</a> of $34.15.</li>
<li>RSI Value: 77.99</li>
<li>BTI Price Action: Shares of British American Tobacco fell slightly to close at $33.38 on Wednesday.</li>
</ul>
Altria Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)
<ul>
<li>Altria Group will report its second-quarter and first-half business results on July 31. The company's stock gained around 6% over the past month and has a <a href="https://www.benzinga.com/quote/MO">52-week high</a> of $49.92.</li>
<li>RSI Value: 76.01</li>
<li>MO Price Action: Shares of Altria closed at $49.42 on Wednesday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39954998/over-1m-bet-on-united-security-bancshares-check-out-these-3-stocks-insiders-are-buying">Over $1M Bet On United Security Bancshares? Check Out These 3 Stocks Insiders Are Buying</a></li>
</ul>

Top 3 Defensive Stocks That Are Ticking Portfolio Bombs

British American Tobacco shares are trading higher following H1 earnings.

Earnings

British American Tobacco H1 Adj. EPS 169.3p Down From 181.6p YoY, Revenue £12.34B Down From £13.44B YoY

After an extensive scientific review, the Food and Drug Administration (FDA) <a href="https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-vuse-alto-tobacco-flavored-e-cigarette-pods-and-accompanying-power-unit" target="_blank" rel="noreferrer noopener">issued </a>marketing granted orders to R.J. Reynolds Vapor Company, a subsidiary of British American Tobacco P.L.C. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>), for the Vuse Alto Power Unit and six Vuse Alto tobacco-flavored pods, which are sealed, pre-filled, and non-refillable.
While the FDA is authorizing the marketing of these tobacco products in the U.S., it does not mean these tobacco products are safe nor are they &#8220;FDA approved.&#8221;
Additionally, this action is not an authorization or indication of appropriateness to market these products as modified risk tobacco products.
FDA evaluates premarket tobacco product application (PMTAs) based on a public health standard that considers the risks and benefits of the product to the population as a whole.
After reviewing the company&#8217;s applications, FDA determined there was sufficient evidence to demonstrate that permitting marketing of the products would be appropriate for the protection of public health.
The applicant showed that these tobacco-flavored products could benefit adults who smoke cigarettes sufficiently to outweigh the risks, including to youth.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39796877/philip-morris-expands-us-operations-with-600m-colorado-plant" rel="noreferrer noopener">Philip Morris Expands US Operations With $600M Colorado Plant</a>
According to the 2023 National Youth Tobacco Survey, Vuse was among the most commonly reported brands used by middle and high school students currently using e-cigarettes.
Only 6.4% of these students reported using tobacco-flavored products. To further mitigate youth use, FDA has placed stringent marketing restrictions on the new products and will closely monitor their marketing practices.
However, these products have continued to be sold while the ruling is challenged in court, <a target="_blank" href="https://www.wsj.com/business/retail/u-s-authorizes-tobacco-flavored-vuse-e-cigarettes-f6f6f3b5?mod=retail_news_article_pos1" rel="noreferrer noopener">reported </a>The Wall Street Journal.
The decision by the FDA comes after a previous ruling prohibiting Reynolds American to sell the brand&#8217;s menthol versions.
The FDA&#8217;s decisions on Vuse are part of a comprehensive federal review of the vaping industry, requiring all U.S. e-cigarette manufacturers to provide evidence that their products are less harmful than cigarettes and offer a public-health benefit by helping smokers switch to a safer option.
The report further noted that Vuse Alto products accounted for approximately 40% of U.S. e-cigarette sales in stores tracked by Nielsen IQ for the year ending June 15, with menthol flavors making up $1.5 billion of the total sales.
Tobacco flavors represented $479 million in sales. Reynolds American also markets Camel and Newport cigarettes and recently introduced a nicotine-free vaping brand called Sensa.
Price Action: BTI shares are trading higher by 0.15% at $33.09 in premarket at last check Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Midjourney
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/06/39377842/whats-happening-with-tobacco-major-philip-morris-shares-on-tuesday" target="_blank" rel="noreferrer noopener">Swedish Match North America subpoenaed over D.C. flavored sales</a></li>
</ul>

Equities

Media

FDA Approves Tobacco-Flavored Vuse Alto E-Cigarettes: Details

Trump Administration has withdrawn the proposed ban on menthol cigarettes and flavored cigars in the U.S., which has been looming over the tobacco ...

Menthol ban withdrawal 'significant positive' for Altria and BAT, says Citi

UBS upgraded British American Tobacco (BTI) to Buy from Neutral with a price target of 3,900 GBp, up from 3,000 GBp. The firm views the stock's val...

British American Tobacco upgraded to Buy from Neutral at UBS

Consumer staples stocks catch a bid as AI anxiety leads to risk-off trading

British American Tobacco: The Dividend Will Rise Again

Deutsche Bank analyst Damian McNeela maintained a Buy rating on British American Tobacco (BATS – Research Report) today and set a price target of £...

Deutsche Bank  Keeps Their Buy Rating on British American Tobacco (BATS)

Momentum shift: DeepSeek spurs flight from growth to defensive as XLP outperforms XLK

British American Tobacco: Our Favorite Consumer Staples Stock For 2025

How To Strategically Allocate $25,000: Positioning Your Dividend Portfolio For 2025

Dividends And Dynamite: 10 High-Yield Blue-Chip Bargains You Don't Want To Miss

Altria Group: Despite Some Key Wins, The Opportunity Looks Mediocre At Best

AAPL

AMZN

ARCC

ASML

BBSEY

BRBR

BTAFF

BYND

CART

COST

COTY

GOOG

GOOGL

HAIN

ILMN

IMBBF

IMBBY

JAPAF

JAPAY

KVUE

MAIN

MNST

MSFT

NVDA

PYPL

RBGLY

SCHD

SCHO

TCPC

TMGEF

USFD

VICI

Press Releases

BTI IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages British American Tobacco p.l.c Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action Commenced by the Firm – BTI

MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that British American Tobacco p.l.c. Investors with Substantial Losses Have Opportunity to Lead Case

The Gross Law Firm Notifies British American Tobacco p.l.c. Investors of a Class Action Lawsuit and Upcoming Deadline - BTI

BTI Investors Have Opportunity to Lead British American Tobacco p.l.c. Securities Fraud Lawsuit

BRITISH AMERICAN TOBACCO 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against British American Tobacco p.l.c - BTI

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against British American Tobacco p.l.c. - BTI

DEADLINE ALERT for BTI, XPOF, LUXH, and AMLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

BTI DEADLINE TODAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages British American Tobacco p.l.c Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action Commenced by the Firm – BTI

Small Cap

Charlotte's Web Reports 2024 First Quarter Financial Results

AMLX

CWBHF

LUXH

TSX:CWEB

XPOF

Ispire Technology

Altria Group

Philip Morris International Inc Common Stock

Philip Morris Intl

RLX Technology Inc. American Depositary Shares, each representing the right to receive one (1) Class A ordinary share

Comments

British American Tobacco

空売り

British American Tobacco (NYSE:BTI) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル